Hartmann D, Schneider M A, Lenz B F, Talmadge J E
Preclinical Screening Laboratory, Frederick Cancer Research Facility, Md.
Pathol Immunopathol Res. 1987;6(1):37-50. doi: 10.1159/000157040.
Polyinosinic-polycytidylic acid [poly(I,C)] is a double-stranded RNA that is a potent interferon (IFN) inducer in rodents and, when suitably complexed with poly-L-lysine and carboxymethylcellulose [poly(I,C)-LC], also in primates and humans. In addition, poly(I,C)-LC has shown significant therapeutic activity in a number of preclinical tumor models and significant toxicity in both the preclinical and clinical settings. To better understand the toxicity of this agent, particularly in light of the previously reported bell-shaped dose response curve for immunomodulation and therapeutic activity, we undertook a pharmacological/toxicological study of poly(I,C)-LC. These experiments revealed that the injection of toxic doses of poly(I,C)-LC significantly reduced the body weight of animals and induced serological and histological abnormalities. We found that poly(I,C) is the toxic moiety of poly(I,C)-LC and that both agents induced pulmonary thrombosis as well as hepatic necrosis. The hepatic necrosis was reflected in serum enzyme levels, with significant increases in ornithine carbonyl transferase, serum glutamic oxaloacetic transaminase and serum glutamic pyruvic transaminase levels. In addition, reduced platelet counts indicated a significant increase in platelet consumption in agreement with the thrombosis. There were, however, only minor changes in prothrombin and activated prothrombin times. It was of interest that coincubating poly(I,C)-LC and peritoneal macrophages in vitro resulted in the production of tumor necrosis factor, which has a similar pattern of toxicity; this finding suggests that poly(I,C)-LC's pattern of toxicity may be associated with the induction of TNF and/or IFN.
聚肌苷酸-聚胞苷酸[聚(I,C)]是一种双链RNA,在啮齿动物中是一种有效的干扰素(IFN)诱导剂,当与聚-L-赖氨酸和羧甲基纤维素[聚(I,C)-LC]适当复合时,在灵长类动物和人类中也是如此。此外,聚(I,C)-LC在许多临床前肿瘤模型中显示出显著的治疗活性,并且在临床前和临床环境中均具有显著毒性。为了更好地了解该药物的毒性,特别是鉴于先前报道的免疫调节和治疗活性的钟形剂量反应曲线,我们对聚(I,C)-LC进行了药理学/毒理学研究。这些实验表明,注射毒性剂量的聚(I,C)-LC会显著降低动物体重,并诱导血清学和组织学异常。我们发现聚(I,C)是聚(I,C)-LC的毒性部分,并且这两种药物都会诱导肺血栓形成以及肝坏死。肝坏死反映在血清酶水平上,鸟氨酸羰基转移酶、血清谷氨酸草酰乙酸转氨酶和血清谷氨酸丙酮酸转氨酶水平显著升高。此外,血小板计数减少表明与血栓形成一致的血小板消耗显著增加。然而,凝血酶原时间和活化凝血酶原时间仅有轻微变化。有趣的是,在体外将聚(I,C)-LC与腹腔巨噬细胞共同孵育会导致肿瘤坏死因子的产生,其具有类似的毒性模式;这一发现表明聚(I,C)-LC的毒性模式可能与肿瘤坏死因子和/或干扰素的诱导有关。